While the whole world is still fighting the pandemic, China, where the dreadful novel virus originated, has been the culprit amidst the allegation that was man-made. As supreme nations are stuck with the blame game, and on the verge of calling a trade war, China dropped exciting news.
Besides its authenticity, news that a Chinese laboratory is on the last leg of developing a drug which claims to have the power to bring the coronavirus pandemic to a halt. It is to the common knowledge that various nations, including India, is racing to come up with a vaccine, in the wake of which, China’s update came as bittersweet news to the scientific community.
According to the reports from Chinese media, the drug being tested by scientists at China’s prestigious Peking University could not only shorten the recovery time for those infected but even offer short-term immunity from the virus. In support of their claims, the lab authorities released a statement that the drug has been successful at the animal testing stage.
“As we injected the drug to mice, it showed promising results in five days as the viral load was reduced by a factor of 2,500,” said Sunney Xie, director of the university’s Beijing Advanced Innovation Centre for Genomics. The team reportedly has been working day in and day out over single-cell genomics rather than immunology or virology. Unlike counties like India which is still speculating over the results of plasma therapy, China has a very good track record in this treatment while almost 700 patients recovered.
If everything goes by the plan, this potential drug which can neutralise the antibodies would hit the market by the end of the year. Meanwhile, China government stated that five potential coronavirus vaccines at the human trial stage. However, as per the WHO reports, a vaccine would take not less than 12 to 18 months to get approved.